0001415889-14-003736.txt : 20141126 0001415889-14-003736.hdr.sgml : 20141126 20141126182902 ACCESSION NUMBER: 0001415889-14-003736 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141126 FILED AS OF DATE: 20141126 DATE AS OF CHANGE: 20141126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11085 TORREYANA ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 11085 TORREYANA ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mills Roger CENTRAL INDEX KEY: 0001368190 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 141254698 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BOULEVARD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 form4-11262014_031154.xml X0306 4 2014-11-26 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001368190 Mills Roger 11085 TORREYANA ROAD #100 SAN DIEGO CA 92121 false true false false EVP, DEVELOPMENT AND CMO Common Stock 2014-11-26 4 M 0 25000 0 A 43550 D Common Stock 2014-11-26 4 S 0 25000 30.0906 D 18550 D Stock Option (right to buy) 1.55 2014-11-26 4 M 0 25000 0 D 2020-03-11 Common Stock 25000 139035 D Includes 916 shares acquired on November 29, 2013 and 1,859 shares acquired on May 30, 2014 by Dr. Mills under the ACADIA Pharmaceuticals Employee Stock Purchase Plan. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2014. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.18 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range. 25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments. /s/ Glenn F. Baity, Attorney-in-Fact 2014-11-26